Capecitabine-based long-term radiotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Capecitabine-based long-term radiotherapy, covering 2023-03-22 to 2023-03-22. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial [Phase 2]